Physician Associate
Oxford University Hospital , United Kingdom
Jemma Larham is an early career researcher affiliated with Oxford University Hospitals and the Oxford Translational Myeloma Centre at the University of Oxford. Her research is focused on the early detection of myeloma, with a particular interest in diagnostic innovations and risk stratification in precursor conditions. She is currently involved in studies exploring the clinical utility of EXENT® QIP-MS in the evaluation of plasma cell dyscrasias. Jemma aspires to pursue a DPhil, building on her interest in advancing early diagnostic strategies for myeloma. This is her first abstract as first author to be presented at an international conference.